Kither Biotech is biopharmaceutical company developing signal transduction modulators for the treatments of rare respiratory diseases.
Kither Biotech was founded in November 2011 as a spin-off of the University of Turin, initially providing a spectrum of in vitro and in vivo screening services to pharmaceutical companies. Over the years, Kither has gained extensive expertise with murine preclinical models of respiratory diseases, and its research and development activities are now directed towards the development of new compounds for the treatment of those pathologies.
